StoneTurn sought Howbridge’s help to revitalize their brand reposition firm for domestic and international expansion.

A breath of fresh air.

InCarda Therapeutics

InCarda Therapeutics, a biopharmaceutical company out of Palo Alto, CA, discovered a faster and more-effective way to treat cardiovascular disease: via the inhalation route. This novel approach brings a huge advantage – it offers a lower dose, with more control, ensuring the effects are extremely targeted and patients are not over-exposed to the drug.


Partner Since

Life Sciences

Bay Area, CA

Dig in & team up.

When we met, InCarda was riding strong momentum from a Series A round of funding. They were looking to gear up for a Series B and release to a wider audience which included future investors, Key Opinion Leaders (KOLs) and potential partners. In addition, they were about to begin their clinical trials and needed a communications strategy to reach potential patients who were in need of a better solution.

Key Initiatives Included:

Developed authentic brand and value proposition to attract investors.


Key Initiatives Included:

Partner with commercial & regulatory team on product packaging branding.


Key Initiatives Included:

Direct engagement with executive team for culture-building activities for recruitment and retention.


Key Initiatives Included:

Enhance digital footprint for US and OUS market engagement.


Key Initiatives Included:

Align with regulatory team in developing patient and physician facing Instructions for Use.


“I cannot say enough good things about the experience working with Howbridge. The value of our partnership goes well beyond tactical elements.

I liked the way they became a strategic partner for InCarda – as a startup, we needed a more integrated, comprehensive approach. I’ve already recommended Howbridge to several people, and the team is currently working with many of my parent companies.”

– Grace E. Colón, Ph.D., Former Chief Executive Officer, InCarda Therapeutics

A brand built for international growth.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed pretium libero eget felis lobortis, eu auctor nulla iaculis. Curabitur turpis mauris, porttitor at blandit non, laoreet id arcu. Mauris nec semper erat. Nunc non dolor faucibus.

Seed to Series D completion.

Attracted new top-level VC firm investment.

Oversubscribed Series B.

First Patients enrolled in Phase 2 Clinical Trial.

Attracted top BOD and SAB expansion with top VC advisors.

From the moment we began working with Howbridge, they truly served as members of our team. There is no task too large or small – from strategic conversations to the most tedious details, Howbridge delivers high-quality solutions to complex growth problems.